Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study

Background & Aims: The aim of this study was to investigate gut microbiome (GM) dynamics in relation to carbapenem-resistant Enterobacterales (CRE) colonization, CRE infection, and non-CRE infection development within 2 months after liver transplant (LT). Methods: A single-center, prospectiv...

Full description

Bibliographic Details
Published in:JHEP Reports
Main Authors: Federica D’Amico, Matteo Rinaldi, Renato Pascale, Marco Fabbrini, Maria Cristina Morelli, Antonio Siniscalchi, Cristiana Laici, Simona Coladonato, Matteo Ravaioli, Matteo Cescon, Simone Ambretti, Pierluigi Viale, Patrizia Brigidi, Silvia Turroni, Maddalena Giannella
Format: Article
Language:English
Published: Elsevier 2024-04-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555924000405
_version_ 1850106750563254272
author Federica D’Amico
Matteo Rinaldi
Renato Pascale
Marco Fabbrini
Maria Cristina Morelli
Antonio Siniscalchi
Cristiana Laici
Simona Coladonato
Matteo Ravaioli
Matteo Cescon
Simone Ambretti
Pierluigi Viale
Patrizia Brigidi
Silvia Turroni
Maddalena Giannella
author_facet Federica D’Amico
Matteo Rinaldi
Renato Pascale
Marco Fabbrini
Maria Cristina Morelli
Antonio Siniscalchi
Cristiana Laici
Simona Coladonato
Matteo Ravaioli
Matteo Cescon
Simone Ambretti
Pierluigi Viale
Patrizia Brigidi
Silvia Turroni
Maddalena Giannella
author_sort Federica D’Amico
collection DOAJ
container_title JHEP Reports
description Background & Aims: The aim of this study was to investigate gut microbiome (GM) dynamics in relation to carbapenem-resistant Enterobacterales (CRE) colonization, CRE infection, and non-CRE infection development within 2 months after liver transplant (LT). Methods: A single-center, prospective study was performed in patients undergoing LT from November 2018 to January 2020. The GM was profiled through 16S rRNA amplicon sequencing of a rectal swab taken on the day of transplantation, and fecal samples were collected weekly until 1 month after LT. A subset of samples was subjected to shotgun metagenomics, including resistome dynamics. The primary endpoint was to explore changes in the GM in the following groups: (1) CRE carriers developing CRE infection (CRE_I); (2) CRE carriers not developing infection (CRE_UI); (3) non-CRE carriers developing microbial infection (INF); and (4) non-CRE carriers not developing infection (NEG). Results: Overall, 97 patients were enrolled, and 91 provided fecal samples. Of these, five, nine, 22, and 55 patients were classified as CRE_I, CRE_UI, INF, and NEG, respectively. CRE_I patients showed an immediate and sustained post-LT decrease in alpha diversity, with depletion of the GM structure and gradual over-representation of Klebsiella and Enterococcus. The proportions of Klebsiella were significantly higher in CRE_I patients than in NEG patients even before LT, serving as an early marker of subsequent CRE infection. CRE_UI patients had a more stable and diverse GM, whose compositional dynamics tended to overlap with those of NEG patients. Conclusions: GM profiling before LT could improve patient stratification and risk prediction and guide early GM-based intervention strategies to reduce infectious complications and improve overall prognosis. Impact and implications: Little is known about the temporal dynamics of gut microbiome (GM) in liver transplant recipients associated with carbapenem-resistant Enterobacterales (CRE) colonization and infection. The GM structure and functionality of patients colonized with CRE and developing infection appeared to be distinct compared with CRE carriers without infection or patients with other microbial infection or no infection and CRE colonization. Higher proportions of antimicrobial-resistant pathogens and poor representation of bacteria and metabolic pathways capable of promoting overall host health were observed in CRE carriers who developed infection, even before liver transplant. Therefore, pretransplant GM profiling could improve patient stratification and risk prediction and guide early GM-based intervention strategies to reduce infectious complications and improve overall prognosis.
format Article
id doaj-art-e5bdc2d21af74cf2be61b341f183f458
institution Directory of Open Access Journals
issn 2589-5559
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
spelling doaj-art-e5bdc2d21af74cf2be61b341f183f4582025-08-20T00:01:57ZengElsevierJHEP Reports2589-55592024-04-016410103910.1016/j.jhepr.2024.101039Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational studyFederica D’Amico0Matteo Rinaldi1Renato Pascale2Marco Fabbrini3Maria Cristina Morelli4Antonio Siniscalchi5Cristiana Laici6Simona Coladonato7Matteo Ravaioli8Matteo Cescon9Simone Ambretti10Pierluigi Viale11Patrizia Brigidi12Silvia Turroni13Maddalena Giannella14Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, ItalyDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; Department of Integrated Management of Infectious Risk, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; Department of Integrated Management of Infectious Risk, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, Italy; Corresponding author. Address: Infectious Diseases Unit, IRCCS Policlinico Sant’Orsola, Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 11, 40138 Bologna, Italy.Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, ItalyInternal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyDivision of Anesthesiology, Department of Anesthesia and Intensive Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyDivision of Anesthesiology, Department of Anesthesia and Intensive Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; Department of Integrated Management of Infectious Risk, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyGeneral Surgery and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; General Surgery and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyMicrobiology Operative Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; Department of Integrated Management of Infectious Risk, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyMicrobiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyUnit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, ItalyDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; Department of Integrated Management of Infectious Risk, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, Bologna, ItalyBackground & Aims: The aim of this study was to investigate gut microbiome (GM) dynamics in relation to carbapenem-resistant Enterobacterales (CRE) colonization, CRE infection, and non-CRE infection development within 2 months after liver transplant (LT). Methods: A single-center, prospective study was performed in patients undergoing LT from November 2018 to January 2020. The GM was profiled through 16S rRNA amplicon sequencing of a rectal swab taken on the day of transplantation, and fecal samples were collected weekly until 1 month after LT. A subset of samples was subjected to shotgun metagenomics, including resistome dynamics. The primary endpoint was to explore changes in the GM in the following groups: (1) CRE carriers developing CRE infection (CRE_I); (2) CRE carriers not developing infection (CRE_UI); (3) non-CRE carriers developing microbial infection (INF); and (4) non-CRE carriers not developing infection (NEG). Results: Overall, 97 patients were enrolled, and 91 provided fecal samples. Of these, five, nine, 22, and 55 patients were classified as CRE_I, CRE_UI, INF, and NEG, respectively. CRE_I patients showed an immediate and sustained post-LT decrease in alpha diversity, with depletion of the GM structure and gradual over-representation of Klebsiella and Enterococcus. The proportions of Klebsiella were significantly higher in CRE_I patients than in NEG patients even before LT, serving as an early marker of subsequent CRE infection. CRE_UI patients had a more stable and diverse GM, whose compositional dynamics tended to overlap with those of NEG patients. Conclusions: GM profiling before LT could improve patient stratification and risk prediction and guide early GM-based intervention strategies to reduce infectious complications and improve overall prognosis. Impact and implications: Little is known about the temporal dynamics of gut microbiome (GM) in liver transplant recipients associated with carbapenem-resistant Enterobacterales (CRE) colonization and infection. The GM structure and functionality of patients colonized with CRE and developing infection appeared to be distinct compared with CRE carriers without infection or patients with other microbial infection or no infection and CRE colonization. Higher proportions of antimicrobial-resistant pathogens and poor representation of bacteria and metabolic pathways capable of promoting overall host health were observed in CRE carriers who developed infection, even before liver transplant. Therefore, pretransplant GM profiling could improve patient stratification and risk prediction and guide early GM-based intervention strategies to reduce infectious complications and improve overall prognosis.http://www.sciencedirect.com/science/article/pii/S2589555924000405Gut microbiomeCarbapenem-resistant EnterobacteralesLiver transplantAntibiotic resistanceGut resistome
spellingShingle Federica D’Amico
Matteo Rinaldi
Renato Pascale
Marco Fabbrini
Maria Cristina Morelli
Antonio Siniscalchi
Cristiana Laici
Simona Coladonato
Matteo Ravaioli
Matteo Cescon
Simone Ambretti
Pierluigi Viale
Patrizia Brigidi
Silvia Turroni
Maddalena Giannella
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
Gut microbiome
Carbapenem-resistant Enterobacterales
Liver transplant
Antibiotic resistance
Gut resistome
title Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
title_full Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
title_fullStr Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
title_full_unstemmed Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
title_short Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
title_sort gut microbiome dynamics and enterobacterales infection in liver transplant recipients a prospective observational study
topic Gut microbiome
Carbapenem-resistant Enterobacterales
Liver transplant
Antibiotic resistance
Gut resistome
url http://www.sciencedirect.com/science/article/pii/S2589555924000405
work_keys_str_mv AT federicadamico gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT matteorinaldi gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT renatopascale gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT marcofabbrini gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT mariacristinamorelli gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT antoniosiniscalchi gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT cristianalaici gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT simonacoladonato gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT matteoravaioli gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT matteocescon gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT simoneambretti gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT pierluigiviale gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT patriziabrigidi gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT silviaturroni gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy
AT maddalenagiannella gutmicrobiomedynamicsandenterobacteralesinfectioninlivertransplantrecipientsaprospectiveobservationalstudy